About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

miRNA and Myokines in Patients With PAH | Clinical Trials | Clareo Health

Back to clinical trial search

WITHDRAWNNANCT03905083

miRNA and Myokines in Patients With PAH

The overall objective of this study is to fulfill the Pilot study (miRNA and Myokines Acutely-expressed During Exercise) goal to Investigate the excretion of skeletal muscle-derived miRNA and myokines...

Lead sponsor: University of Pittsburgh•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of Pittsburgh

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients undergoing a RHC/iCPET procedure at the UPMC Presbyterian Hospital Catheterization Lab.
•18 years of age or older
•Able to read and understand the informed consent.
•Subjects who have signed the iCPET registry consent.

Exclusion Criteria

•Pregnant women
•people under 18
•Who are unable to read and understand the informed consent.
•Subjects prescribed anticoagulant therapy

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

NCT07481981 · Pulmonary Arterial Hypertension

RECRUITINGPhase 3

A Clinical Study of Sotatercept (MK-7962) in People With Pulmonary Arterial Hypertension (MK-7962-038)

NCT07218029 · Pulmonary Arterial Hypertension

RECRUITINGPhase 3

An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)

NCT07365332 · Pulmonary Arterial Hypertension

RECRUITINGPhase 1/2

A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension

Mobile Health Intervention to Improve Exercise in Pediatric PH

NCT06549452 · Pulmonary Arterial Hypertension

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 3, 2022Terms

Trial snapshot

StatusWITHDRAWN

PhaseNA

Enrollment—

Start dateDec 2021

Last updatedMar 3, 2022

Condition

Pulmonary Arterial Hypertension

Locations shown

Division of Pulmonary, Allergy and Critical Care Medicine

Pittsburgh, Pennsylvania

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 3, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions